Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
MACACHA has designed natural protein shakes that have the nourishing power of plants, no artificial ingredients and have a positive impact on the environment, as well as looking beautiful on the kitchen counter!
days to go:
Expired
investment:
£98,378
A decentralised banking platform with already more than £13.5m dedicated for software development. BABB intends to become a licensed bank in the UK and is raising funds for the capital required to do so. The company aims to allow anyone access to a bank account, as well as a mobile app for customers to make payments, lend money and exchange currencies.
days to go:
Expired
investment:
£1,362,430
Cheran's Bakery, based in Kent, specializes in crafting sumptuous sweet treats available online and at their expanding chain of five stores. With sales exceeding £1.2 million since inception, they create indulgent and creatively packaged products, baked daily for maximum freshness and luxury. Their high-quality, visually appealing shop designs and 'Instagrammable' offerings have attracted over 24,000 social media followers, amplifying brand recognition, while their focus on delivering exceptional customer experiences fosters word-of-mouth promotion.
days to go:
Expired
investment:
£325,482
TOAD is Oxford's first distillery, crafting gin, rye whiskey and vodka in bespoke stills using locally sourced populations of ancient heritage grain. Since launching in July 2017 they have achieved over £134k of revenue.
days to go:
Expired
investment:
£868,100
Signature Brew strives to craft beer that enhances the musical experience. Since 2011, their mission has been to create more collaborative beers with bands and musicians than any other brand globally. Through the success of their flagship beers, Studio Lager and Roadie All-Night IPA, they aim to spread their vision of uniting people through exceptional beer, music, and memorable experiences on a national and international scale.
Continuing their original objective of improving the beer scene at beloved venues and festivals, Signature Brew remains committed to this ethos. Their direct-to-consumer customer base is expanding across the UK, driven by partnerships with artists and venues within their community. Operating from their cutting-edge brewery in East London, which includes an iconic live music venue, they consistently produce award-winning beer while fervently supporting grassroots music.
days to go:
Expired
investment:
£872,392
